Elite 50% OFF Act now – get top investing tools

00

Days

00

Hours

00

Mins

00

Sec

Register Now!

Merus N.V.

Contributing Author

Recent Articles by Merus N.V.

Oct-24	Merus' Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety MRUS GlobeNewswire
Oct-14	Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics MRUS GlobeNewswire
Oct-13	Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics MRUS GlobeNewswire
Aug-28	Merus to Present at the 2025 Wells Fargo Healthcare Conference MRUS GlobeNewswire
Aug-06	Merus to Present at the Canaccord Genuity 45th Annual Growth Conference MRUS GlobeNewswire
Aug-05	Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update MRUS GlobeNewswire
Aug-04	Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MRUS GlobeNewswire
Jun-04	Merus N.V. Announces Pricing of Public Offering of Common Shares MRUS GlobeNewswire
Jun-03	Merus N.V. Announces Proposed Public Offering of Common Shares MRUS GlobeNewswire
May-27	Merus to Present at Upcoming Investor Conferences MRUS GlobeNewswire
May-22	Merus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC MRUS GlobeNewswire
May-15	Merus Announces the Journal Publication of Petosemtamab Mechanism of Action MRUS GlobeNewswire
May-08	Merus to Present at BofA Securities 2025 Health Care Conference MRUS GlobeNewswire
May-07	Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update MRUS GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.